互联网 qkzz.net
全刊杂志网:首页 > 医药医学 > 《临床肿瘤学医学期刊》 > 2005年第02期
《临床肿瘤学医学期刊》
临床肿瘤学医学期刊2005年第02期封面 购买
收藏
投稿

《临床肿瘤学医学期刊》2005年第02期

phase i and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors
phase ii study of proteasome inhibitor bortezomib in relapsed or refractory b-cell non-hodgkin's lymphoma
phase ii clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-hodgkin's lymphoma and mantle cell lymphoma
phenotypic heterogeneity in multiple myeloma families
rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma
effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the swiss group for clin..
relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epit..
discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy
changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors
phase i study of sequential vaccinations with fowlpox-cea(6d)-tricom alone and sequentially with vaccinia-cea(6d)-tricom, with and without granulocyte-macrophage co..
breast cancer treatment guidelines in older women
randomized phase iii trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer
androgen suppression plus radiation versus radiation alone for patients with stage d1/pathologic node-positive adenocarcinoma of the prostate: updated results based..
evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer
individualized predictions of disease progression following radiation therapy for prostate cancer
outcome predictors for the increasing psa state after definitive external-beam radiotherapy for prostate cancer
validation and extension of the memorial sloan-kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma
phase iii study of matrix metalloproteinase inhibitor prinomastat in non
influence of sex on toxicity and treatment outcome in small-cell lung cancer
egfr mutations in non
molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: imatinib target exploration consortium study b2225
lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction
relationship between mycn copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype
angiogenesis inhibitor im862 is ineffective against aids-kaposi's sarcoma in a phase iii trial, but demonstrates sustained, potent effect of highly active antiretro..
imatinib-induced regression of aids-related kaposi's sarcoma
phase i clinical and pharmacokinetic study of the novel raf kinase and vascular endothelial growth factor receptor inhibitor bay 43-9006 in patients with advanced r..
blockade of platelet-derived growth factor receptor-beta by cdp860, a humanized, pegylated di-fab', leads to fluid accumulation and is associated with increased tum..
randomized pharmacokinetic and pharmacodynamic study of docetaxel: dosing based on body-surface area compared with individualized dosing based on cytochrome p450 ac..
combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions
phase i trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-hodgkin's lymphoma―a randomized p..
rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade i non-hodgkin's lymphoma: a phase ii trial in the north central cancer treatme..
phase ii trial of individualized rituximab dosing for patients with cd20-positive lymphoproliferative disorders
long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase iii trials
hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation th..
analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor fo..
[18f]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non
clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the austrian breast and colorectal cancer study ..
concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage iii non
patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase ii hoosier oncology group study
first and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase i..
randomized trial of 30 versus 20 gy in the adjuvant treatment of stage i testicular seminoma: a report on medical research council trial te18, european organisation..
randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer ..
irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer―a groupe tumeurs digestives of the federation nationale des centres..
selective excision of metastatic brain tumors originating in the motor cortex with preservation of function
paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome
molecular staging in stage ii and iii melanoma patients and its effect on long-term survival
profile of patients with kaposi's sarcoma in the era of highly active antiretroviral therapy
does a history of childhood sexual abuse affect sexual outcomes in breast cancer survivors
predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the international society of pediatric oncology liver tumor study grou..
psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study
should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis systematic re-evaluation of clinical ..
communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis
购买 收藏 投稿
往期回顾
2006年第20期
2006年第02期
2006年第01期
2005年第12期
2005年第11期
2005年第10期
2005年第09期
2005年第08期
2005年第07期
2005年第06期
2005年第05期
2005年第04期
关键字
支持中国杂志产业发展,请购买、订阅纸质杂志,欢迎杂志社提供过刊、样刊及电子版。
关于我们 | 网站声明 | 刊社管理 | 网站地图 | 联系方式 | 中图分类法 | RSS 2.0订阅 | EMS快递查询
全刊杂志赏析网 2017